Gabapentin Capsule
Product Images NDC 50090-7389

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Equation)

A mathematical formula illustrating creatinine clearance (CLCr) calculation, including variables for age in years, weight in kilograms, serum creatinine in mg/dL, and an adjustment factor of 0.85 for female patients. This formula is commonly used for renal function assessment.*

FDA Label Image

Fig 1 (Fig 1)

A line graph titled 'Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1' showing mean pain scores over 8 weeks. The graph compares placebo and gabapentin (3600 mg/day) groups, with mean pain scores on the y-axis and weeks on the x-axis. Gabapentin shows a decreasing trend in pain scores compared to placebo.*

FDA Label Image

Fig 2 (Fig 2)

A line chart showing weekly mean pain scores from Study 2 in an ITT population across seven weeks. It compares placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day during both 4-week dose titration and 4-week fixed dose periods.*

FDA Label Image

Fig 3 (Fig 3)

A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) at different dosages. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg. Study 2 shows 14% for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg, with statistical significance indicated by asterisks.*

FDA Label Image

Fig 4 (Fig 4)

Chart showing the responder rate difference (%) from placebo for gabapentin by daily dose (600, 900, 1200, 1800 mg) in adjunctive therapy studies for patients aged 12 years and older with partial seizures. Three studies (a, b, c) are represented with varying responder rates at each dose level.*

FDA Label Image

Structure (Struct)

Chemical structure diagram showing the molecular arrangement of gabapentin, featuring a cyclohexane ring attached to aminomethyl and carboxymethyl groups.*

FDA Label Image

Label Image (Lbl500907389)

GABAPENTIN 100 mg capsules label from A-S Medication Solutions, Libertyville, IL. The label specifies each capsule contains 100 mg of gabapentin, USP. Storage instructions are to keep at 77 degrees Fahrenheit. The package contains 90 capsules. The label includes product and lot numbers, a NDC code 50090-7389-0, and a QR code with dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.